MingSight Pharmaceuticals, Inc. — Form D
MingSight Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-22. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-11-22
- Form: D
- Accession: 0001567619-21-020919
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 2
- Date of first sale: 2021-11-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-421986
Issuer
- Name: MingSight Pharmaceuticals, Inc.
- CIK: 0001883584
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 11318 VILLAGE RIDGE RD, SAN DIEGO, CA, 92131
- Phone: 858-699-7681
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Michael Niesman | Director | San Diego, CA |
| Xintao Xia | Director | San Diego, CA |
| Kai Zhang | Director | San Jose, CA |
| Michael Niesman | Executive Officer | San Diego, CA |
| Kai Zhang | Executive Officer | San Jose, CA |
More